For small pharmas and biotechs approaching a commercial launch, agility and execution are more valuable than waiting for a ...

The global white (industrial) biotechnology market is experiencing significant growth, driven by increasing demand for sustainable alternatives to traditional petroleum-based products. White ...

Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for ...

"The collaborations involve the development of renewable energy and the commercialisation of sustainable biotechnology products, aligning with the aspirations of the National Biotechnology Policy ...

Very early in the history of modern agricultural biotechnology ... its eventual commercialization may mean that patent protection expires relatively early in a transgenic product's commercial ...

Risk Adjusted Net Present Value Method Developing drugs and biotech products are expensive, time-consuming and risky propositions. With multiple stages of testing, clinical trials and regular ...

("Onconetix" or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research, development and commercialization of innovative solutions for ...

Investing.com -- Citi has expanded its biopharmaceutical research coverage, initiating coverage on seven small- and mid-cap (SMid) biotechnology ... the development and commercialization of ...

Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to ...

Regeneron Pharmaceuticals, a biotechnology company with a long history of large-scale genetics research, plans to buy DNA testing firm 23andMe out of bankruptcy, announcing Monday it was named the ...